Dominique C. Hinshaw

O-GlcNAcylation of GLI Transcription Factors in Hyperglycemic Conditions Augments Hedgehog activity

J. Chatham, R. Samant, Brandon J. Metge, 2018, Laboratory Investigation.

Hedgehog blockade remodels the gut microbiota and the intestinal effector CD8+ T cells in a mouse model of mammary carcinoma

R. Samant, L. Shevde, Craig L. Maynard, 2022, Laboratory Investigation.

Hedgehog blockade remodels the gut microbiota and the intestinal effector CD8+ T cells in a mouse model of mammary carcinoma

R. Samant, L. Shevde, Craig L. Maynard, 2022, Laboratory Investigation.

The Tumor Microenvironment Innately Modulates Cancer Progression.

L. Shevde, Dominique C. Hinshaw, Dominique C Hinshaw, 2019, Cancer research.

Hedgehog Signaling Regulates Metabolism and Polarization of Mammary Tumor-Associated Macrophages

S. Ballinger, J. Rathmell, Atul Kumar, 2021, Cancer Research.

Quantitative Longitudinal Imaging Reveals that Inhibiting Hedgehog Activity Alleviates the Hypoxic Tumor Landscape

A. Sorace, R. Samant, L. Shevde, 2021, Molecular Cancer Research.

Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study

R. Schilsky, Rui Li, A. Alva, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Olaparib in Patients With Pancreatic Cancer With BRCA1/2 Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study

R. Schilsky, A. Alva, C. Calfa, 2024, JCO Precision Oncology.

Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.

R. Schilsky, C. Calfa, K. Gogineni, 2024, JCO precision oncology.

Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.

R. Schilsky, F. Meric-Bernstam, M. von Mehren, 2023, JCO precision oncology.